Indaptus Therapeutics, Inc. (INDP) stock
Close on Nov 13, 2026Market cap $422.38MP/E –Yield –
Earnings
Indaptus Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Indaptus Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 11, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026before the open | – | – | -$0.02 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 15, 2026before the open | – | – | -$0.23 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025before the open | – | – | -$9.09 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025before the open | – | – | -$0.32 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 13, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | – | – | -$0.32 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024before the open | – | – | -$0.47 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024before the open | – | – | -$0.45 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 13, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023after the close | – | – | -$0.47 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | – | – | -$0.39 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | -$0.51 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 17, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022after the close | – | – | -$0.42 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 8, 2022before the open | – | – | -$0.46 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | – | – | -$0.41 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 21, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | – | – | -$0.81 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Indaptus Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Indaptus Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Indaptus Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Update
- News
- Update
- Results
- Results
- Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq RulesNews
- News
- Results
- Results
- News
See a number that looks wrong?